ALGS vs BRO · rev $3.6M vs P/E 30, rev $4.80B
Aligos Therapeutics Inc (ALGS) versus Brown & Brown Inc (BRO) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
ALGS currently screens at market cap $44.1M. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Not investment advice. Open the ALGS and BRO stock pages for the full models.
Not investment advice.